Dawn Wilson

Vice President, Clinical Operations and Development

Dawn Wilson is the Vice President of Clinical Operations and Development at Cadent Therapeutics. Ms. Wilson most recently was Vice President, Clinical Operations and Program Management at Albireo Pharma where she led the clinical operations team executing their phase 3 programs in orphan pediatric liver diseases.  Previously, she was Vice President, Clinical Operations and Data Management at Acceleron Pharma where she built and managed the clinical team including clinical operations, data management, clinical outsourcing, medical writing and pharmacovigilance to support multiple programs across hematologic, neuromuscular and pulmonary diseases. Prior to Acceleron, Ms. Wilson held other positions of growing responsibilities in data management at Idenix Pharmaceuticals (acquired by Merck), Wyeth (acquired by Pfizer), Vertex Pharmaceuticals and Genetics Institute (acquired by Wyeth).

Ms. Wilson received her B.S from Tufts University.

Our Team

Dawn Wilson

Vice President, Clinical Operations and Development

Dawn Wilson is the Vice President of Clinical Operations and Development at Cadent Therapeutics. Ms. Wilson most recently was Vice President, Clinical Operations and Program Management at Albireo Pharma where she led the clinical operations team executing their phase 3 programs in orphan pediatric liver diseases.  Previously, she was Vice President, Clinical Operations and Data Management at Acceleron Pharma where she built and managed the clinical team including clinical operations, data management, clinical outsourcing, medical writing and pharmacovigilance to support multiple programs across hematologic, neuromuscular and pulmonary diseases. Prior to Acceleron, Ms. Wilson held other positions of growing responsibilities in data management at Idenix Pharmaceuticals (acquired by Merck), Wyeth (acquired by Pfizer), Vertex Pharmaceuticals and Genetics Institute (acquired by Wyeth).

Ms. Wilson received her B.S from Tufts University.

Our Team

Dawn Wilson

Vice President, Clinical Operations and Development

Dawn Wilson is the Vice President of Clinical Operations and Development at Cadent Therapeutics. Ms. Wilson most recently was Vice President, Clinical Operations and Program Management at Albireo Pharma where she led the clinical operations team executing their phase 3 programs in orphan pediatric liver diseases.  Previously, she was Vice President, Clinical Operations and Data Management at Acceleron Pharma where she built and managed the clinical team including clinical operations, data management, clinical outsourcing, medical writing and pharmacovigilance to support multiple programs across hematologic, neuromuscular and pulmonary diseases. Prior to Acceleron, Ms. Wilson held other positions of growing responsibilities in data management at Idenix Pharmaceuticals (acquired by Merck), Wyeth (acquired by Pfizer), Vertex Pharmaceuticals and Genetics Institute (acquired by Wyeth).

Ms. Wilson received her B.S from Tufts University.

Our Team